Cargando…
Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer
Triple-negative breast cancer (TNBC), which is the most malignant subtype of breast cancer (BC), accounts for 10%–20% of all BC cases. TNBC, which occurs more frequently in young women, is characterized by high rates of cell proliferation and metastasis and poor prognosis. Chemotherapy is the primar...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411013/ https://www.ncbi.nlm.nih.gov/pubmed/34513294 http://dx.doi.org/10.1016/j.omtn.2021.06.017 |
_version_ | 1783747217077567488 |
---|---|
author | Tian, Tian Zhao, Yangzhi Zheng, Jingying Jin, Shunzi Liu, Zhongshan Wang, Tiejun |
author_facet | Tian, Tian Zhao, Yangzhi Zheng, Jingying Jin, Shunzi Liu, Zhongshan Wang, Tiejun |
author_sort | Tian, Tian |
collection | PubMed |
description | Triple-negative breast cancer (TNBC), which is the most malignant subtype of breast cancer (BC), accounts for 10%–20% of all BC cases. TNBC, which occurs more frequently in young women, is characterized by high rates of cell proliferation and metastasis and poor prognosis. Chemotherapy is the primary systemic therapeutic strategy for TNBC. However, chemotherapy is largely unsuccessful, and effective targeted therapies for TNBC have not been established. Therefore, it is a matter of great urgency to identify precise molecular targets for the promising prognosis of patients with TNBC. Circular RNAs (circRNAs), which are a type of non-coding RNAs (ncRNAs), are abundantly expressed in the eukaryotic cells and exhibit diverse cellular functions. The roles of circRNAs are to sponge microRNA or RNA-binding proteins, regulate gene expression, and serve as templates for translation. Here, we review the current findings on the potential of circRNAs as a diagnostic, prognostic, and therapeutic biomarker for TNBC. However, further studies are essential to elucidate the functions of circRNAs in TNBC. This review also discusses the current limitations and future directions of TNBC-associated circRNAs, which can facilitate the translation of experimental research into clinical application. |
format | Online Article Text |
id | pubmed-8411013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-84110132021-09-10 Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer Tian, Tian Zhao, Yangzhi Zheng, Jingying Jin, Shunzi Liu, Zhongshan Wang, Tiejun Mol Ther Nucleic Acids Review Triple-negative breast cancer (TNBC), which is the most malignant subtype of breast cancer (BC), accounts for 10%–20% of all BC cases. TNBC, which occurs more frequently in young women, is characterized by high rates of cell proliferation and metastasis and poor prognosis. Chemotherapy is the primary systemic therapeutic strategy for TNBC. However, chemotherapy is largely unsuccessful, and effective targeted therapies for TNBC have not been established. Therefore, it is a matter of great urgency to identify precise molecular targets for the promising prognosis of patients with TNBC. Circular RNAs (circRNAs), which are a type of non-coding RNAs (ncRNAs), are abundantly expressed in the eukaryotic cells and exhibit diverse cellular functions. The roles of circRNAs are to sponge microRNA or RNA-binding proteins, regulate gene expression, and serve as templates for translation. Here, we review the current findings on the potential of circRNAs as a diagnostic, prognostic, and therapeutic biomarker for TNBC. However, further studies are essential to elucidate the functions of circRNAs in TNBC. This review also discusses the current limitations and future directions of TNBC-associated circRNAs, which can facilitate the translation of experimental research into clinical application. American Society of Gene & Cell Therapy 2021-07-02 /pmc/articles/PMC8411013/ /pubmed/34513294 http://dx.doi.org/10.1016/j.omtn.2021.06.017 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tian, Tian Zhao, Yangzhi Zheng, Jingying Jin, Shunzi Liu, Zhongshan Wang, Tiejun Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer |
title | Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer |
title_full | Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer |
title_fullStr | Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer |
title_full_unstemmed | Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer |
title_short | Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer |
title_sort | circular rna: a potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411013/ https://www.ncbi.nlm.nih.gov/pubmed/34513294 http://dx.doi.org/10.1016/j.omtn.2021.06.017 |
work_keys_str_mv | AT tiantian circularrnaapotentialdiagnosticprognosticandtherapeuticbiomarkerforhumantriplenegativebreastcancer AT zhaoyangzhi circularrnaapotentialdiagnosticprognosticandtherapeuticbiomarkerforhumantriplenegativebreastcancer AT zhengjingying circularrnaapotentialdiagnosticprognosticandtherapeuticbiomarkerforhumantriplenegativebreastcancer AT jinshunzi circularrnaapotentialdiagnosticprognosticandtherapeuticbiomarkerforhumantriplenegativebreastcancer AT liuzhongshan circularrnaapotentialdiagnosticprognosticandtherapeuticbiomarkerforhumantriplenegativebreastcancer AT wangtiejun circularrnaapotentialdiagnosticprognosticandtherapeuticbiomarkerforhumantriplenegativebreastcancer |